Sesen Bio Inc.

NASDAQ:SESN   3:58:30 PM EDT
0.52
0.00 (+0.21%)
Earnings Announcements

Sesen Bio Reports First Quarter 2022 Financial Results

Published: 05/09/2022 13:48 GMT
Sesen Bio Inc. (SESN) - Sesen Bio Reports First Quarter 2022 Financial Results and Business Update.
Sesen Bio Inc- $170 Million in Cash and Cash Equivalents As of March 31, 2022, Expected to Fund Current Operating Plan Into Q4 of 2024.
Sesen Bio Inc - Qtrly Loss per Share $0.00.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.